You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 11,564,922


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,564,922 protect, and when does it expire?

Patent 11,564,922 protects RINVOQ and is included in one NDA.

This patent has fifteen patent family members in nine countries.

Summary for Patent: 11,564,922
Title:Methods of treating crohn's disease and ulcerative colitis
Abstract:The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
Inventor(s):Aileen L. Pangan, Roopal B. Thakkar, Steven JUNGERWIRTH, Ana Paula Machado de LACERDA, Anne M. ROBINSON, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder, Wen Zhou
Assignee:AbbVie Inc
Application Number:US17/732,070
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,564,922

Introduction to U.S. Patents

U.S. patents are granted by the U.S. Patent and Trademark Office (USPTO) and provide inventors with exclusive rights to their inventions for a specified period. To delve into the specifics of a patent, it is crucial to understand its various components, particularly the scope and claims.

Structure of a U.S. Patent

A U.S. patent is composed of several key sections, each serving a distinct purpose:

Document Number and Type

  • The document number, prefixed with "US," indicates it is a U.S. patent. The code "B2" signifies that the patent has a previously published application[1].

Title and Abstract

  • The title of the invention is limited to 500 characters or less and provides a brief description of the invention[1].

Drawings

  • The drawings section includes black and white illustrations that detail the technical aspects of the invention[1].

Specification

  • This is a written description of the invention, including discussions of prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. The specification must be detailed enough for anyone with ordinary skill in the same technical field to understand it[1].

Claims

  • The claims section defines the scope of protection for the patent. It begins with phrases like "I claim" or "What is claimed" and includes numbered claims. These claims legally define the boundaries of the invention, similar to how a property deed defines physical boundaries[1].

The Importance of Claims in a Patent

Defining Patent Scope

  • Claims are the most critical part of a patent as they delineate what is protected by the patent. The scope of a patent is essentially determined by its claims, which must be clear, concise, and specific[3].

Independent and Dependent Claims

  • Patents typically include both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[1].

Metrics for Measuring Patent Scope

  • Researchers use metrics such as independent claim length and independent claim count to measure patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Analyzing the Claims of United States Patent 11,564,922

To analyze the claims of a specific patent like United States Patent 11,564,922, one must carefully review the claims section.

Example of a Claim

  • Here is an example of a claim from a similar patent to illustrate the structure:
    • "1. A portable electronic device, comprising: a first housing; a second housing coupled to the first housing and movable relative thereto between a closed position and an open position; an antenna positioned in the first housing; a low frequency shield coupled to the antenna and adapted to inhibit changes to the frequency response of the antenna when the portable electronic device is moved between the open position and the closed position; and a high frequency chassis resonator coupled to the low frequency shield and adapted to increase high frequency sensitivity of the antenna"[1].

Breaking Down the Claims

  • Each claim must be analyzed for its specific elements and how they contribute to the overall scope of the patent.
  • For instance, the claim above defines a portable electronic device with specific components and their functions, which together form the protected invention.

Patentability Requirements

For a patent to be granted, the invention must meet several criteria:

Utility

  • The invention must be useful and provide some tangible benefit[4].

Novelty

  • The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge[4].

Nonobviousness

  • The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[4].

The Role of the USPTO

The USPTO is responsible for evaluating patent applications and ensuring they meet the patentability requirements.

Examination Process

  • A USPTO examiner reviews the application, considering statutory definitions, judicial guidance, and the Manual of Patent Examining Procedure (MPEP)[4].

Granting Patents

  • If the application meets all requirements, the USPTO issues a patent, granting the inventor exclusive rights for a period of 20 years from the date of application filing[4].

Legal Rights and Enforcement

A valid patent grants its holder the right to exclude others from making, using, offering for sale, or selling the invention in the United States. This includes the right to exclude others from importing the invention into the U.S.[4].

Infringement

  • Violating these exclusive rights constitutes patent infringement, which can result in legal action and monetary damages[4].

Policy and Innovation

The U.S. patent system is designed to balance the incentives for innovation with the need to ensure that patents are of high quality and do not overly restrict competition.

Current Issues and Debates

  • There are ongoing debates about patent quality, patent validity challenges, and the need for reforms such as a potential small claims patent court to address issues related to patent litigation costs and accessibility[5].

Key Takeaways

  • Claims Define Scope: The claims section of a patent is crucial as it legally defines what is protected by the patent.
  • Patentability Requirements: Inventions must be useful, novel, and nonobvious to be patentable.
  • USPTO Role: The USPTO evaluates patent applications to ensure they meet patentability criteria.
  • Legal Rights: A valid patent grants exclusive rights to the inventor for a specified period.
  • Policy Considerations: The patent system aims to balance innovation incentives with ensuring high-quality patents.

FAQs

Q: What is the primary purpose of the claims section in a U.S. patent?

A: The claims section defines the scope of protection for the patent, outlining what is legally protected by the patent.

Q: How long does a U.S. patent grant exclusive rights to the inventor?

A: A U.S. patent grants exclusive rights for a period of 20 years from the date the patent application was filed.

Q: What are the key criteria for an invention to be considered patentable?

A: An invention must be useful, novel, and nonobvious to be considered patentable.

Q: Who is responsible for evaluating patent applications in the United States?

A: The U.S. Patent and Trademark Office (USPTO) is responsible for evaluating patent applications.

Q: What happens if someone violates the exclusive rights granted by a patent?

A: Violating the exclusive rights granted by a patent constitutes patent infringement, which can result in legal action and monetary damages.

Sources

  1. How to Read a U.S. Patent - Patents and Designs - Research Guides
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Patents and Innovation Policy - CRS Reports
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,564,922

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-001 Aug 16, 2019 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS ⤷  Try for Free
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-002 Jan 14, 2022 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS ⤷  Try for Free
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-003 Mar 16, 2022 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 11,564,922

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2018230500 ⤷  Try for Free
Australia 2024203642 ⤷  Try for Free
Brazil 112019018576 ⤷  Try for Free
Canada 3052873 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.